Nature Publishing Group, publisher of Nature, and other science journals and reference works
Nature
my account e-alerts subscribe register
   
Monday 16 November 2009
Journal Home
Current Issue
AOP
Archive
Download PDF
References
Export citation
Export references
Send to a friend
More articles like this

Letters to Nature
Nature 349, 414 - 418 (31 January 1991); doi:10.1038/349414a0

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

Lechoslaw Turski, Karin Bressler, Klaus Jürgen Rettig, Peter-Andreas Löschmann & Helmut Wachtel

Research Laboratories of Sobering AG, D-1000 Berlin 65, Germany

INTAKE of MPTP (l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine) leads to symptoms of Parkinson's disease and produces degeneration of nigrostriatal dopaminergic neurons in humans, giving rise to the hypothesis that this disorder may be caused by endogenous or environmental toxins1–3. Excitation mediated by dicarboxylic amino acids such as L-glutamate or L-aspartate, has been claimed to be involved in pathogenesis of neurodegenerative disorders4. We therefore sought to determine whether antagonists active at the NMDA or quisqualate subtypes of L-glutamate receptors prevent toxicity of either MPP+ (l-methyl-4-phenyl-pyridinium ion5, the active metabolite of MPTP6) or the selective dopaminergic neurotoxin 6-OHDA in the rat substantia nigra pars compacta. We report here that certain selective NMDA antagonists (AP7, CPP, MK-801)7, but not the preferential quisqualate antagonists CNQX and NBQX,8 provided short-term (up to 24 h) protection against MPP+ toxicity when coadministered into the substantia nigra. Systemic administration of CPP or MK-801 also offered temporary protection for up to 4 h against MPP+ toxicity. Repeated systemic administration of either compound prolonged protection against MPP+ challenge. Repeated administration for at least 24 h also led to permanent protection, still evident 7 days after intranigral administration of MPP+.

------------------

References
1. Langston, J. W., Ballard, P., Tetrud, J. W. & Irwin, I. Science 219, 979−980 (1983). | PubMed | ISI | ChemPort |
2. Burns, R. S. et al. Proc. natn. Acad. Sci. U.S.A. 80, 4546−4550 (1983). | ChemPort |
3. Bradbury, A. J. et al. Nature 319, 56−57 (1986). | Article | PubMed | ChemPort |
4. Olney, J. W. In Frontiers in Excitatory Amino Acid Research (eds Cavalheiro, E., Lehmann, J. & Turski, L.) 589−596 (Liss, New York, 1988). | ChemPort |
5. Markey, S. P., Johanessen, J. N., Chiueh, C. C., Burns, R. S. & Herkenham, M. A. Nature 311, 464−467 (1984). | Article | PubMed | ChemPort |
6. Heikkila, R. E., Manzino, L., Cabbat, F. S. & Duvoisin, R. C. Nature 311, 467−469 (1984). | Article | PubMed | ISI | ChemPort |
7. Olvermann, H. J., Jones, A. W. & Watkins, J. C. Nature 307, 460−462 (1984). | Article | PubMed | ISI | ChemPort |
8. Sheardown, M. J., Nielsen, E. O., Hansen, A. J., Jacobsen, P. & Honore, T. Science 247, 571−574 (1990). | PubMed | ISI | ChemPort |
9. Fallon, J. H. & Loughlin, S. E. In The Rat Nervous System (ed. Paxinos, G.) 353−403 (Academic, Sydney, 1985).
10. Sonsalla, P. K., Nicklas, W. J. & Heikkila, R. E. Science 243, 398−400 (1989). | PubMed | ChemPort |
11. Nicklas, W. J., Vyas, I. & Heikkila, R. E. Life Sci. 36, 2503−2508 (1985). | Article | PubMed | ISI | ChemPort |
12. Ramsay, R. R., Salach, J. I. & Singer, T. P. Biochem. biophys. Res. Commun. 134, 743−748 (1986). | Article | PubMed | ISI | ChemPort |
13. Di Monte, D. & Smith, M. T. Rev. Neurosci. 2, 67−82 (1988). | ChemPort |
14. Nowak, L., Bregestovski, P., Ascher, P., Herbet, A. & Prochiantz, A. Nature 307, 462−465 (1984). | Article | PubMed | ISI | ChemPort |
15. Novelli, A., Reilly, J. A., Lysko, P. G. & Henneberry, R. C. Brain Res. 451, 205−212 (1988). | Article | PubMed | ChemPort |
16. Rothman, S. Science 220, 536−538 (1983). | PubMed | ChemPort |
17. Irwin, I., DeLanney, L. E., Di Monte, D. & Langston, J. W. Neurosci. Lett. 101, 83−88 (1989). | Article | PubMed | ChemPort |
18. Johannessen, J. N., Chiueh, C. C., Burns, R. S. & Markey, S. P. Life Sci. 36, 219−224 (1985). | Article | PubMed | ChemPort |
19. Ohya, Y. et al. Neurosci. Lett. 105, 221−226 (1989). | Article | PubMed | ChemPort |
20. Chapman, A., Collins, J. F., Meldrum, B. S. & Westerberg, E. Neurosci. Lett. 37, 75−80 (1983). | Article | PubMed | ChemPort |
21. Compton, R. P., Hood, W. F. & Monahan, J. B. Neurosci. Lett. 84, 339−344 (1988). | Article | PubMed | ChemPort |
22. Vezzani, A. et al. J. Pharmacol. exp. Ther. 249, 278−283 (1989). | PubMed | ChemPort |
23. Gibb, W. R. G., Costall, B., Domeney, A. M., Kelly, M. E. & Naylor, R. J. Brain Res. 461, 361−366 (1988). | Article | PubMed | ChemPort |
24. Sun, C. J. et al. J. neural Transm. 74, 75−86 (1988). | Article | PubMed | ChemPort |
25. Christie-Pope, B. C., Burns, R. S. & Whetsell, W. O. Expl Neurol. 104, 235−240 (1989). | Article | ChemPort |
26. Calne, D. B., Eisen, A., McGeer, E. & Spencer, P. Lancet ii, 1067−1070 (1986).
27. Spencer, P. S. et al. Science 237, 517−522 (1987). | PubMed | ISI | ChemPort |
28. Mawdsley, C. & Ferguson, F. R. Lancet ii, 795−801 (1963).
29. Weiss, J. H. & Choi, D. W. Science 241, 973−975 (1988). | PubMed | ChemPort |
30. Faden, A. I., Demediuk, P., Panter, S. S. & Vink, R. Science 244, 798−800 (1989). | PubMed | ISI | ChemPort |
31. Olney, J. W. et al. Eur. J. Pharmacol. 142, 319−320 (1987). | Article | PubMed | ChemPort |
32. Bormann, J. Eur. J. Pharmacol. 166, 591−592 (1989). | Article | PubMed | ISI | ChemPort |
33. Tetrud, J. W. & Langston, J. W. Science 245, 519−522 (1989). | PubMed | ChemPort |
34. König, J. F. R. & Klippel, R. A. The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem (William and Wilkins, Baltimore, 1963).
35. Fink, R. P. & Heimer, L. Brain Res. 4, 369−374 (1967). | Article | PubMed | ChemPort |



© 1991 Nature Publishing Group
Privacy Policy